Breast Cancer Survivor Runs NYC Marathon Topless

Diagnosed at 31 with a BRCA2 mutation, Lauren Spiezia finished the race in four hours and 54 minutes.

Updated on Nov. 2, 2026 in Cancer

Breast Cancer Survivor Runs NYC Marathon Topless

Lauren Spiezia, a 32-year-old mother from New Jersey, competed in the New York City Marathon on Sunday without a top, running as an official member of Memorial Sloan Kettering Cancer Center's Fred's Team. She finished in four hours and 54 minutes, using anti-chafing tape as makeshift support.

Why it matters

Spiezia said she is running to raise awareness for women and men in treatment and for women unaware of their own risk. Her experience highlights how breast cancer can be diagnosed in women in their thirties, particularly those who carry a hereditary gene mutation.

This is a single patient's account reported alongside the race result, not a clinical study. The source notes that about 1 in 8 U.S. women will be diagnosed with breast cancer during their lifetime, and Spiezia's finish time of four hours and 54 minutes is her official marathon result.

The players

Memorial Sloan Kettering Cancer Center

A New York City cancer hospital and research center known for oncology care and clinical trials across all major cancer types.

The details

Spiezia's cancer was found after she noticed a lump in her breast. Her breast surgeon ordered a mammogram, biopsy and MRI after an initial ultrasound came back benign. She was diagnosed at age 31 with stage 2 triple-negative cancer in one breast and stage 1 ER/PR-positive cancer in the other, and she carries the BRCA2 gene mutation. Treatment included 16 rounds of chemotherapy, eight rounds of immunotherapy, a mastectomy and reconstruction.

Timeline

  1. Age 31: Spiezia is diagnosed with breast cancer and found to carry the BRCA2 mutation.

  2. Sunday, November 1, 2026: Spiezia completes the New York City Marathon topless.

Health Landscape

Hereditary BRCA2 mutations raise breast cancer risk substantially and are a recognized reason clinicians consider genetic testing for younger patients. Cases like this one, diagnosed in the early thirties, sit at the younger end of the population typically affected by breast cancer.

If you have a family history of breast or ovarian cancer, a BRCA mutation, or a diagnosis before age 35, it is worth raising genetic counseling and screening questions with your doctor. Breast lumps should be evaluated promptly, even when an initial ultrasound appears benign.

The takeaway

Spiezia's story shows that breast cancer can appear in women in their thirties, especially those with hereditary mutations. Ask your doctor whether genetic testing is appropriate if breast cancer runs in your family.

Further reading

Explore more cancer coverage to see how survivors across the city are living with and beyond their diagnoses.